Hannah C. Slater
Title
Cited by
Cited by
Year
Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies
L Wu, LL van den Hoogen, H Slater, PGT Walker, AC Ghani, CJ Drakeley, ...
Nature 528 (7580), S86, 2015
1232015
Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies
HC Slater, A Ross, AL Ouédraogo, LJ White, C Nguon, PGT Walker, ...
Nature 528 (7580), S94-S101, 2015
1042015
Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling
H Slater, E Michael
PloS one 7 (2), e32202, 2012
1002012
Oral, ultra–long-lasting drug delivery: application toward malaria elimination goals
AM Bellinger, M Jafari, TM Grant, S Zhang, HC Slater, EA Wenger, S Mo, ...
Science Translational Medicine 8 (365), 365ra157-365ra157, 2016
982016
Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey
JB Parr, R Verity, SM Doctor, M Janko, K Carey-Ewend, BJ Turman, ...
The Journal of infectious diseases 216 (1), 36-44, 2017
812017
The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study
HC Slater, PGT Walker, T Bousema, LC Okell, AC Ghani
The Journal of infectious diseases 210 (12), 1972-1980, 2014
752014
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial
AL Ouédraogo, GJH Bastiaens, AB Tiono, WM Guelbéogo, KC Kobylinski, ...
Clinical Infectious Diseases 60 (3), 357-365, 2015
742015
The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low …
FG Tadesse, HC Slater, W Chali, K Teelen, K Lanke, M Belachew, ...
Clinical infectious diseases 66 (12), 1883-1891, 2018
652018
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
OJ Brady, HC Slater, P Pemberton-Ross, E Wenger, RJ Maude, AC Ghani, ...
The Lancet Global Health 5 (7), e680-e687, 2017
622017
Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda
CJ Chaccour, NR Rabinovich, H Slater, SE Canavati, T Bousema, ...
Malaria journal 14 (1), 243, 2015
572015
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a …
MR Smit, EO Ochomo, G Aljayyoussi, TK Kwambai, BO Abong'o, T Chen, ...
The Lancet Infectious Diseases 18 (6), 615-626, 2018
542018
Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa
OJ Watson, HC Slater, R Verity, JB Parr, MK Mwandagalirwa, A Tshefu, ...
Elife 6, e25008, 2017
432017
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa
SJ O’Hanlon, HC Slater, RA Cheke, BA Boatin, LE Coffeng, SDS Pion, ...
PLoS neglected tropical diseases 10 (1), e0004328, 2016
392016
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
BD Foy, H Alout, JA Seaman, S Rao, T Magalhaes, M Wade, S Parikh, ...
The Lancet 393 (10180), 1517-1526, 2019
382019
The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density
HC Slater, A Ross, I Felger, NE Hofmann, L Robinson, J Cook, ...
Nature communications 10 (1), 1-16, 2019
352019
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases
M Miglianico, M Eldering, H Slater, N Ferguson, P Ambrose, RS Lees, ...
Proceedings of the National Academy of Sciences 115 (29), E6920-E6926, 2018
332018
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
HC Slater, JT Griffin, AC Ghani, LC Okell
Malaria journal 15 (1), 10, 2016
332016
Screening for an ivermectin slow-release formulation suitable for malaria vector control
C Chaccour, ÁI Barrio, AGG Royo, DM Urbistondo, H Slater, F Hammann, ...
Malaria journal 14 (1), 102, 2015
332015
Mapping, Bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa
H Slater, E Michael
PloS one 8 (8), e71574, 2013
322013
Modelling co-infection with malaria and lymphatic filariasis
HC Slater, M Gambhir, PE Parham, E Michael
PLoS Computational Biology 9 (6), e1003096, 2013
292013
The system can't perform the operation now. Try again later.
Articles 1–20